北京碧水源科技股份有限公司 对外担保管理办法 （2023年8月） 第一章 总 则 第一条 为规范北京碧水源科技股份有限公司（以下简称"公司"）对外担 保业务，防范债务风险，维护公司权益，根据《中华人民共和国公司法》《中华 人民共和国证券法》《深圳证券交易所创业板股票上市规则》《创业板上市公司 规范运作》《企业国有资产监督管理暂行条例》、国资委《关于加强中央企业资 金内部控制管理有关事项的通知》（国资发〔2021〕19 号文）、国资委《关于 加强中央企业融资担保管理工作的通知》（国资发财评规〔2021〕75 号文）等 法律法规、《北京碧水源科技股份有限公司章程》（以下简称"公司章程"）， 结合公司管理实际，制定本办法。 第二条 本办法所述的"对外担保"是指公司为包括公司所属子公司在内的 第三方提供的担保，承担被担保单位到期不能偿还债务的担保责任，其方式包括 保证、抵押、质押等。公司为自身债务或融资提供的担保不适用本办法。 第三条 本办法所述的担保管理包括担保对象的审核、担保事项的审批、担 保执行的日常管理以及担保事项的监督考核与追责管理。 第四条 本办法适用于公司及其控股子公司（以下统称"各单位"）。各单 位可 ...

证券代码：300070 证券简称：碧水源 公告编号：2023-060 二、审议通过《关于制定公司<对外捐赠管理办法>的议案》。 北京碧水源科技股份有限公司 第五届董事会第四十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京碧水源科技股份有限公司（以下简称"公司"）第五届董事会第四十一 次会议于 2023 年 8 月 9 日上午 9:30 在公司会议室以现场及通讯方式召开，会议 通知于 2023 年 7 月 31 日以电话及电子邮件方式送达。本次会议应参加董事 9 人，实际参加董事 9 人，其中独立董事 3 人。本次董事会的召集和召开符合《中 华人民共和国公司法》和《公司章程》的规定。 会议由公司董事长黄江龙先生主持，经全体董事表决，审议了以下议案： 一、审议通过《关于修订公司<对外担保管理办法>的议案》； 为规范公司对外担保业务，防范债务风险，维护公司权益，根据《中华人民 共和国公司法》《中华人民共和国证券法》《深圳证券交易所创业板股票上市规则》 《创业板上市公司规范运作》《企业国有资产监督管理暂行条例》等法律法规及 《公司章程》的相关规 ...

证券代码：300070 证券简称：碧水源 编号：2023-009 | --- | --- | |--------------------------|------------| | 特定对象调研 ■分析师会议 | | | 媒体采访 | 业绩说明会 | | 新闻发布会 | 路演活动 | | 现场参观 | | 其他 投资者关系活动类别 参会人员 国信证券、华鑫证券 时间 2023 年 7 月 18 日周二 10:00-11:00、16:00—17：00 地点 碧水源大厦 上市公司接待人员 高级副总裁、董秘；证券事务代表 问：我们看到中交集团和公司的协同在逐步释放，想问下公司目前和中交 集团市场方面的协同怎样，海外订单是否有进一步的释放？ 答：自中交集团混改碧水源以来，双方的协同效应也在不断释放，概括来 说，主要体现在战略引领、公司治理、科技创新、业务发展、人才队伍五方面， 这也在去年公司的发展上有所体现。过去一年，公司通过改革创新、重构发展 战略、强化公司治理、优化组织结构、提升精益管理、激发市场活力、勇拓新 领域新赛道等系列举措，实现公司市场与业务快速增长，经营质效稳步提升。 在业务融合方面，我们也通过管理、市 ...

Group 1: Company Overview and Strategic Direction - The company is focusing on wastewater resource utilization and membrane technology, preparing for the implementation of the national water network construction plan [1] - After two years of collaboration with China Communications Construction Company, the company's performance has started to recover, indicating a stable development phase with increasing operational water volume [1] - The company aims to expand the application scenarios of membrane technology, including projects in lithium extraction from salt lakes and industrial zero discharge [1] Group 2: Financial Performance and Growth - The company secured nearly 100 million RMB in orders for lithium extraction membrane products last year and has signed a 150 million RMB order for lithium adsorption agents this year [1] - The return on equity (ROE) is expected to improve as more projects enter stable operation, with current low ROE attributed to many projects being in trial operation or testing phases [1][4] - The gross profit margin for environmental solutions improved from 26% in 2021 to 31% in 2022, while the gross profit margin for drainage engineering increased from below 7% to 12% [4] Group 3: Market Opportunities and Challenges - The company is actively exploring overseas projects in collaboration with China Communications Construction Company, particularly in the context of the Belt and Road Initiative [5] - The national water network construction plan aims to enhance funding sources for water treatment projects, potentially increasing project opportunities for the company [3] - The company faces challenges in the market, including the need for stable funding sources for public-private partnership (PPP) projects, which have historically been a concern in the industry [3] Group 4: Technological Advancements and Product Development - The company is developing small-scale treatment facilities for rural areas, capable of processing 10-500 tons per day, achieving surface water quality standards [5] - The membrane treatment technology is expected to have a larger market space in the future, as it aligns with national policies promoting wastewater resource utilization [4][5] - The company is working on enhancing the competitiveness of its membrane products in various water quality requirements, aiming for broader market penetration [4]

证券代码：300070 证券简称：碧水源 北京碧水源科技股份有限公司投资者关系活动记录表 编号：2023-007 | --- | --- | |--------------------------|------------| | 特定对象调研 ■分析师会议 | | | 媒体采访 | 业绩说明会 | | 新闻发布会 | 路演活动 | | 现场参观 | | 其他 投资者关系活动类别 参会人员 长江证券、建信信托、嘉实基金、嘉合基金、建信投资、建信基金、国泰产险、 敦和资产、西部利得、华夏财富、光大保德、深圳前海道谊、西藏源乘 时间 2023 年 6 月 4 日周日 21：00—22：00 地点 电话会议 上市公司接待人员 高级副总裁、董秘 问：您好，我们关注到《国家水网建设规划纲要》提出水网建设、污水处 理等战略性需求，请问碧水源业务和技术可以为《纲要》提供哪方面服务？ 答：我们最近也很关注《纲要》的相关内容，之前也和一些投资者就这个 问题做了一些探讨。碧水源从创立之初就致力于解决中国"水脏、水少及饮水 不安全"问题。碧水源的膜技术及 MBR 膜组器产品可以解决中国水资源空间及 时空失衡问题，可以通过污水资源化及 ...

证券代码：300070 证券简称：碧水源 北京碧水源科技股份有限公司投资者关系活动记录表 编号：2023-006 | --- | --- | |--------------------------|------------| | 特定对象调研 ■分析师会议 | | | 媒体采访 | 业绩说明会 | | 新闻发布会 | 路演活动 | | 现场参观 | | 其他 投资者关系活动类别 参会人员 国信证券、景熙资产、嘉亿资产等 时间 2023 年 5 月 26 日周五 9：00—10：00 地点 成都 上市公司接待人员 高级副总裁、董秘 各位投资者大家好，感谢大家百忙之中来成都参加碧水源的策略会，根据 初步交流，大家对公司 2022 年年度业绩和 2023 年一季度业绩都有比较深度的 理解，我们就不再对之前的数据进行赘述了。我们重点就最近公司的进展以及 昨晚刚出台的政策来进一步的沟通。 昨天，环保水务行业迎来了一个重大的政策纲要，这次出台的力度和高度 都很大，中共中央、国务院共同印发的《国家水网建设规划纲要》，提出了要 加快构建国家水网，建设现代化高质量水利基础设施网络，统筹解决水资源、 水生态、水环境、水灾害问题， ...

Group 1: Financial Performance - In 2022, the company achieved a net profit attributable to shareholders of 708 million, a growth of 21.36% compared to 2021 [2] - In Q1 2023, the net profit attributable to shareholders was 48.16 million, representing a year-on-year increase of 28.08% [2] - Financial expenses in 2022 decreased by 180 million compared to 2021, while sales and management expenses each decreased by over 100 million [2] Group 2: Strategic Collaborations and Market Expansion - The company's growth is supported by collaboration with China Communications Construction Group, participating in multiple projects across various regions [2] - Internationally, the company is expanding into markets in the Middle East and Africa, with projects in Bangladesh and Pakistan [2] Group 3: Core Competencies and Technological Focus - The company aims to enhance membrane technology, which is its core competitive advantage, through integrated research and development, manufacturing, and application [2] - Key business areas include wastewater resource utilization, high-quality drinking water, seawater desalination, lithium extraction from salt lakes, and zero industrial discharge [3] Group 4: Investment Challenges and Future Outlook - Investment losses are primarily attributed to Yunnan Water, Liangye Technology, and Deqingyuan, with Yunnan Water reporting a loss of 1.158 billion [3] - The company is actively working on improving the operational quality and financial status of these investments [3] Group 5: Innovations in Wastewater Treatment - The company has developed the ICWT technology for decentralized wastewater treatment, successfully implemented in thousands of rural wastewater treatment stations [4] - A unique operational model combining large and small treatment stations has been established to reduce management costs and improve efficiency [4]

Financial Performance - The company's operating revenue for Q1 2023 was ¥1,715,800,906.77, a decrease of 4.84% compared to ¥1,802,999,449.14 in the same period last year[3] - Net profit attributable to shareholders was ¥48,159,161.36, an increase of 28.08% from ¥37,600,355.39 year-on-year[3] - The net profit after deducting non-recurring gains and losses reached ¥33,710,601.22, a significant increase of 2,557.34% compared to ¥1,268,583.00 in the previous year[3] - Total operating revenue for Q1 2023 was CNY 1,715,800,906.77, a decrease of 4.84% compared to CNY 1,802,999,449.14 in Q1 2022[22] - Net profit for Q1 2023 reached CNY 42,162,014.91, an increase of 91.73% compared to CNY 21,972,010.73 in Q1 2022[23] - Total comprehensive income for Q1 2023 was CNY 49,080,698.29, a decrease from CNY 55,314,265.09 in Q1 2022[24] - Basic and diluted earnings per share for Q1 2023 were CNY 0.0133, an increase from CNY 0.0104 in Q1 2022[24] Cash Flow - The net cash flow from operating activities improved to -¥282,981,986.35, a 57.03% reduction in cash outflow compared to -¥658,554,805.19 last year[9] - Cash inflow from operating activities totaled CNY 1,583,836,908.90, down from CNY 1,743,974,247.31 in the same period last year[26] - Cash outflow from operating activities was CNY 1,866,818,895.25, compared to CNY 2,402,529,052.50 in Q1 2022[26] - Net cash flow from investing activities was CNY -572,229,782.25, a decline from CNY 85,119,116.30 in the previous year[26] - Cash inflow from financing activities reached CNY 4,949,188,535.95, up from CNY 3,422,462,375.92 in Q1 2022[27] - Net cash flow from financing activities was CNY 404,881,195.24, down from CNY 693,668,465.08 in the same period last year[27] - The ending balance of cash and cash equivalents was CNY 4,409,751,134.89, compared to CNY 3,938,686,812.79 at the end of Q1 2022[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥73,599,524,231.18, reflecting a 1.31% increase from ¥72,649,393,998.40 at the end of the previous year[3] - Total current assets at the end of the first quarter of 2023 amounted to ¥23,443,864,338.98, a decrease of 0.74% from ¥23,618,660,527.21 at the beginning of the year[19] - The company's long-term equity investments rose from ¥6,014,671,723.23 to ¥6,391,429,830.08, reflecting an increase of about 6.25%[19] - Total liabilities increased to CNY 43,925,979,011.10 in Q1 2023 from CNY 43,203,728,109.92 in Q1 2022, marking a rise of 1.67%[21] - The company's total non-current assets reached CNY 50,155,659,892.20, up from CNY 49,030,733,471.19 in the previous year, reflecting a growth of 2.29%[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 83,302[10] - The largest shareholder, China Urban Holdings Group Co., Ltd., holds a 33.04% stake, amounting to 1,197,585,927 shares[10] - The number of restricted shares for major shareholders was adjusted, with a total of 106,927,769 shares released from restrictions during the reporting period[13] - The company did not engage in any repurchase transactions for its shares during the reporting period[12] Expenses - The company reported a 40.85% increase in tax and additional fees, totaling ¥15,252,266.28, primarily due to increased VAT payments[7] - Financial expenses decreased by 58.37% to ¥65,861,810.04, attributed to lower interest expenses and increased service fees[7] - Total operating costs for Q1 2023 were CNY 1,667,629,027.80, down from CNY 1,773,856,693.80 in the same period last year, reflecting a reduction of 5.98%[22] - Research and development expenses for Q1 2023 amounted to CNY 51,810,722.67, up from CNY 49,837,014.02 in Q1 2022, indicating a growth of 3.94%[23] Management Changes - The company appointed two new vice presidents on January 17, 2023, enhancing its management team[14] Audit Information - The company did not undergo an audit for the Q1 2023 report[28]